Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix
C Risley, MA Clarke, KR Geisinger… - Cancer …, 2020 - Wiley Online Library
Background Understanding racial influences on human papillomavirus (HPV) distribution in
women with atypical squamous cells of undetermined significance (ASCUS) cytology via …
women with atypical squamous cells of undetermined significance (ASCUS) cytology via …
High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human …
D Konopnicki, Y Manigart, C Gilles, P Barlow… - Aids, 2016 - journals.lww.com
Background: Worldwide, human papillomavirus (HPV) 16 and 18 represents 70% of high-
risk (HR) HPV found in cervical cancer. However HIV-positive women are more frequently …
risk (HR) HPV found in cervical cancer. However HIV-positive women are more frequently …
Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities
JR Montealegre, EC Peckham-Gregory… - Gynecologic …, 2018 - Elsevier
Objective HPV genotype distribution varies by race/ethnicity, but is unclear whether there
are racial/ethnic variations in HPV 16/18 integration in the host genome. We describe …
are racial/ethnic variations in HPV 16/18 integration in the host genome. We describe …
Prevalence of high-risk nonvaccine human papillomavirus types in advanced squamous cell carcinoma among individuals of African vs non-African ancestry
EA Williams, J Newberg, KJ Williams… - JAMA Network …, 2021 - jamanetwork.com
High-risk human papillomavirus (hrHPV) causes squamous cell carcinoma (SCC) at a
variety of sites, including cervix, head and neck, anus, vulva, vagina, and penis. The 9-valent …
variety of sites, including cervix, head and neck, anus, vulva, vagina, and penis. The 9-valent …
IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes
AC Vidal, D Skaar, R Maguire, S Dodor… - Infectious Agents and …, 2015 - Springer
Background Despite comparable screening rates for precancerous lesions, higher incidence
and mortality related to cervical cancer in minority women persists. Recent evidence …
and mortality related to cervical cancer in minority women persists. Recent evidence …
Disparities in cervical cancer incidence and mortality: can epigenetics contribute to eliminating disparities?
RL Maguire, AC Vidal, SK Murphy, C Hoyo - Advances in Cancer Research, 2017 - Elsevier
Screening for uterine cervical intraepithelial neoplasia (CIN) followed by aggressive
treatment has reduced invasive cervical cancer (ICC) incidence and mortality. However, ICC …
treatment has reduced invasive cervical cancer (ICC) incidence and mortality. However, ICC …
The impact of racial, geographic, and socioeconomic risk factors on the development of advanced-stage cervical cancer
TC Powell, SE Dilley, S Bae… - Journal of lower …, 2018 - journals.lww.com
Objectives Despite screening, disparities exist in cervical cancer incidence and outcomes.
Demographic factors are associated with diagnosis at advanced stage (AS), but less is …
Demographic factors are associated with diagnosis at advanced stage (AS), but less is …
Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes
JR Montealegre, I Varier, CG Bracamontes… - Ethnicity & …, 2019 - Taylor & Francis
Objective: There are currently three licensed human papillomavirus (HPV) vaccines that
protect against cervical cancer. Here we compare the prevalence of bi-, quadri-, and …
protect against cervical cancer. Here we compare the prevalence of bi-, quadri-, and …
[HTML][HTML] Human Papillomavirus genotyping and p16INK4a expression in cervical lesions: a combined test to avoid cervical cancer progression
Y Zouheir, T Fechtali, N Elgnaoui - Journal of Cancer Prevention, 2016 - ncbi.nlm.nih.gov
Cervical cancer is a major public health problem in Morocco. The cervical cancer has a long
precancerous period that provides an opportunity for the screening and treatment. Improving …
precancerous period that provides an opportunity for the screening and treatment. Improving …
Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016
J Liu, S Ma, C Qin, S Zheng, Z Chen, Y Huang… - Archives of …, 2020 - Springer
In this study, the prevalence and genotype distribution of human papillomavirus (HPV) in
49,793 women aged 25–64 years were determined by fluorescent real-time polymerase …
49,793 women aged 25–64 years were determined by fluorescent real-time polymerase …